CHE Chemed Corp

Price (delayed)

$537.12

Market cap

$8.13B

P/E Ratio

28.6

Dividend/share

$1.6

EPS

$18.78

Enterprise value

$7.96B

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of ...

Highlights
Chemed's quick ratio has soared by 132% YoY and by 22% from the previous quarter
Chemed's equity has increased by 34% YoY and by 7% from the previous quarter
The debt is down by 12% year-on-year but it is up by 4.8% since the previous quarter

Key stats

What are the main financial stats of CHE
Market
Shares outstanding
15.14M
Market cap
$8.13B
Enterprise value
$7.96B
Valuations
Price to book (P/B)
6.86
Price to sales (P/S)
3.54
EV/EBIT
21.78
EV/EBITDA
18.63
EV/Sales
3.47
Earnings
Revenue
$2.29B
EBIT
$365.67M
EBITDA
$427.54M
Free cash flow
$302.94M
Per share
EPS
$18.78
Free cash flow per share
$20.03
Book value per share
$78.29
Revenue per share
$151.68
TBVPS
$69.31
Balance sheet
Total assets
$1.73B
Total liabilities
$544.14M
Debt
$146.14M
Equity
$1.18B
Working capital
$257.64M
Liquidity
Debt to equity
0.12
Current ratio
1.91
Quick ratio
1.74
Net debt/EBITDA
-0.39
Margins
EBITDA margin
18.6%
Gross margin
35.5%
Net margin
12.4%
Operating margin
14.8%
Efficiency
Return on assets
17.5%
Return on equity
26.6%
Return on invested capital
66.1%
Return on capital employed
25.3%
Return on sales
15.9%
Dividend
Dividend yield
0.3%
DPS
$1.6
Payout ratio
8.5%

CHE stock price

How has the Chemed stock price performed over time
Intraday
-0.14%
1 week
0.53%
1 month
-0.3%
1 year
-0.25%
YTD
-8.15%
QTD
-1.01%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.29B
Gross profit
$813.47M
Operating income
$340.08M
Net income
$283.41M
Gross margin
35.5%
Net margin
12.4%
The net income has grown by 18% year-on-year and by 4% since the previous quarter
The net margin is up by 12% year-on-year and by 3.3% since the previous quarter
CHE's gross profit is up by 7% year-on-year
The revenue rose by 6% year-on-year

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
P/E
28.6
P/B
6.86
P/S
3.54
EV/EBIT
21.78
EV/EBITDA
18.63
EV/Sales
3.47
The EPS has increased by 17% YoY and by 3.7% from the previous quarter
The price to earnings (P/E) is 15% lower than the last 4 quarters average of 33.5 and 2.3% lower than the 5-year quarterly average of 29.3
Chemed's equity has increased by 34% YoY and by 7% from the previous quarter
The P/B is 27% less than the 5-year quarterly average of 9.4 and 15% less than the last 4 quarters average of 8.1
CHE's P/S is 7% below its last 4 quarters average of 3.8
The revenue rose by 6% year-on-year

Efficiency

How efficient is Chemed business performance
The company's return on invested capital rose by 19% YoY and by 2.5% QoQ
The ROE has contracted by 14% YoY and by 3.3% from the previous quarter
The ROS has increased by 7% YoY

Dividends

What is CHE's dividend history
DPS
$1.6
Dividend yield
0.3%
Payout ratio
8.5%
Recent dividends

Financial health

How did Chemed financials performed over time
Chemed's quick ratio has soared by 132% YoY and by 22% from the previous quarter
CHE's current ratio has soared by 105% YoY and by 19% from the previous quarter
The debt is 88% smaller than the equity
CHE's debt to equity is down by 37% year-on-year and by 8% since the previous quarter
Chemed's equity has increased by 34% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.